Cymbalta sales catalyst for Lilly's overall sales

Share this content:
Lilly credited increased Cymbalta sales for a 7% gain in overall sales for the 3rd Quarter, and said marketing and administrative costs were up 12%, due to increased advertising and promotion for the brand.
Share this content:
Scroll down to see the next article